Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 14;25(1):605.
doi: 10.1186/s12872-025-05044-5.

Pheochromocytoma with acute heart failure as a complication-emphasis on the etiology of acute heart failure for diagnosis and treatment: a case report

Affiliations

Pheochromocytoma with acute heart failure as a complication-emphasis on the etiology of acute heart failure for diagnosis and treatment: a case report

Ke Wang et al. BMC Cardiovasc Disord. .

Abstract

Background: The primary causes of heart failure include myocardial damage and structural abnormalities. In addition to cardiovascular disease, noncardiovascular disease can also lead to heart failure. Identifying these etiologies is critical for accurate diagnosis and timely, targeted treatment.

Case presentation: The patient presented with a 10-month history of recurrent chest tightness and shortness of breath, with symptoms significantly worsening 6 hours before admission. She was diagnosed with acute heart failure in the decompensated phase, complicated by cardiogenic shock. Stabilization was achieved via an intra-aortic balloon pump (IABP) and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Further evaluation revealed pheochromocytoma as the underlying cause of acute heart failure. The patient underwent successful surgical resection of the pheochromocytoma, with no recurrence of heart failure symptoms observed during follow-up.

Conclusion: Acute heart failure is a rare but critical condition with rapid onset, often presenting as an emergency. Effective management necessitates life support therapy to stabilize the patient, allowing time for further diagnostic and therapeutic measures.

Keywords: Acute heart failure; Case Report; IABP; Pheochromocytoma; VA-ECMO.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The studies involving human participants were reviewed and approved by the Ethics Committee of Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (College of Integrated Traditional Chinese and Western Medicine Clinical Medicine) (2025–042-JY). Consent for publication: Consent for publication Written informed consent was obtained from the patient for publication of this case report. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Bedside electrocardiogram suggesting sinus tachycardia (105 beats/minute) with ST-segment depression in the chest leads
Fig. 2
Fig. 2
Chest CT: image suggesting exudative changes in both lungs, a hypodense shadow in the right adrenal region, and no difference in arterial CTA findings
Fig. 3
Fig. 3
Cardiac ultrasound image suggesting left ventricular wall thickening, ejection fraction rebound, and normal ventricular size
Fig. 4
Fig. 4
Pictures sequentially showing the results of three pathological sections and HE staining

Similar articles

References

    1. Writing Committee Members, ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022;28(5):e1-e167. 10.1016/j.cardfail.2022.02.010. - PubMed
    1. Petroni T, Harrois A, Amour J, et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation*. Crit Care Med. 2014;42(9):2075–82. 10.1097/CCM.0000000000000410. (PMID: 24810530) - PubMed
    1. Chen Z, Gao Y, Lin Y. Perspectives and considerations of IABP in the era of ECMO for cardiogenic shock. Adv Ther. 2023;40(10):4151–65. 10.1007/s12325-023-02598-8. (Epub 2023 Jul 18 PMID: 37460921). - PubMed
    1. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline [published correction appears in J Clin Endocrinol Metab. 2023 Apr 13;108(5):e200. 10.1210/clinem/dgad064]. J Clin Endocrinol Metab. 2014;99(6):1915–42. 10.1210/jc.2014-1498. - PubMed
    1. Zhang R, Gupta D, Albert SG. Pheochromocytoma as a reversible cause of cardiomyopathy: analysis and review of the literature. Int J Cardiol. 2017;15(249):319–23. 10.1016/j.ijcard.2017.07.014. - PubMed

LinkOut - more resources